The increases in potassium concentrations are greater with succinylcholine than with rocuronium-sugammadex in outpatient surgery: A randomized, multicentre trial

Canadian Journal of Anesthesia

Volumn 61, Issue 5, 2014, Pages 423-432

  Sabo, Daniel ^a   Jahr, Jonathan ^b   Pavlin, Janet ^c   Philip, Beverly ^d   Shimode, Noriko ^e,h   Rowe, Everton ^f   Woo, Tiffany ^f   Soto, Roy ^g  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF UTAH HOSPITAL   (United States)

^f MERCK RESEARCH LABORATORIES   (United States)

^g WILLIAM BEAUMONT HOSPITAL   (United States)

^h HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM; ROCURONIUM; SUGAMMADEX; SUXAMETHONIUM; ANDROSTANE DERIVATIVE; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT; NEUROMUSCULAR DEPOLARIZING AGENT;

ADULT; ADVERSE OUTCOME; AMBULATORY SURGERY; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFICACY; DRUG SAFETY; ETHNICITY; FEMALE; HUMAN; HYPERKALEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; MIDDLE AGED; PROCEDURES; TIME;

ADULT; AMBULATORY SURGICAL PROCEDURES; ANDROSTANOLS; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR DEPOLARIZING AGENTS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; POTASSIUM; SUCCINYLCHOLINE; TIME FACTORS;

EID: 84899938463     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-014-0128-7     Document Type: Article

References (12)

1. Bettelli G. Which muscle relaxants should be used in day surgery and when. Curr Opin Anaesthesiol 2006; 19: 600-5. (Pubitemid 44722006)
2. Martyn JA, Richtsfeld M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology 2006; 104: 158-69.
3. Gronert GA. Cardiac arrest after succinylcholine: mortality greater with rhabdomyolysis than receptor upregulation. Anesthesiology 2001; 94: 523-9. (Pubitemid 32198464)
4. Piotrowski AJ, Fendler WM. Hyperkalemia and cardiac arrest following succinylcholine administration in a 16-year-old boy with acute nonlymphoblastic leukemia and sepsis. Pediatr Crit Care Med 2007; 8: 183-5. (Pubitemid 46568571)
5. Taylor B, MacEwen P. Asystole after alfentanil-succinylcholine. Can J Anaesth 1989; 36: 255-6. (Pubitemid 19110414)
6. Booij LH. Is succinylcholine appropriate or obsolete in the intensive care unit? Crit Care 2001; 5: 245-6. (Pubitemid 32976330)
7. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107: 130-7.
8. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part 1: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111: 120-8.
9. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112: 1013-22.
10. Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology 2008; 109: 816-24.
11. Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol 2010; 27: 874-81.
12. Raman SK, San WM . Fasciculations, myalgia and biochemical changes following succinylcholine with atracurium and lidocaine pretreatment. Can J Anaesth 1997; 44: 498-502. (Pubitemid 27317743)